Octagon Capital Advisors LP Celldex Therapeutics, Inc. Transaction History

Octagon Capital Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $1.18 Million - $2.13 Million	-52,372 Reduced 6.89%	707,526 $28.1 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $52,170 - $71,145	-1,500 Reduced 0.2%	759,898 $27.3 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $5.79 Million - $11.2 Million	200,000 Added 35.63%	761,398 $41.1 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $7.77 Million - $14.4 Million	-480,000 Reduced 46.09%	561,398 $11.6 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $15.6 Million - $23.7 Million	1,041,398 New	1,041,398 $18.2 Million

199

65.9M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.15B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Octagon Capital Advisors LP with notifications on news.